Skip to main content
. 2023 Jul 21;11:1222693. doi: 10.3389/fbioe.2023.1222693

TABLE 6.

Biodistribution studies.

Organ Marketed PI NF NFM
Lung (µg) 1.45 ± 0.25 2.04 ± 0.27 a 2.73 ± 0.19 a
Liver (µg) 16.69 ± 0.20 18.34 ± 1.75 22.94 ± 0.81 a
Spleen (µg) 2.97 ± 0.56 3.26 ± 1.01 3.94 ± 0.91
Kidney (µg) 1.79 ± 0.31 2.40 ± 0.87 2.29 ± 0.26
Heart (µg) 1.66 ± 0.65 1.52 ± 0.52 1.57 ± 0.45

Data was represented as Mean ± SD (n = 6).

a

= (p < 0.05); PI = powder for injection; NF , Nanoformulation without lyoprotectant; NFM , nanoformulation with mannitol.